article thumbnail

Join HCCA for the 28th Annual Compliance Institute

ACRP blog

Few industries have a need to understand the complexities of compliance more than clinical research. The importance of compliance in clinical research cannot be stressed enough. This year’s Compliance Institute features more than 100 educational sessions across 14 unique learning tracks.

article thumbnail

Transforming Clinical Trial Management: The Shift from Point Systems to Platform Solutions

Cloudbyz

This shift is not merely technological but represents a fundamental rethinking of how clinical trials are conducted, promising to enhance efficiency, compliance, and the overall quality of research outcomes. Cost Efficiency: The operational costs associated with maintaining multiple point systems can be significant.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Untapped opportunity: the growing potential of clinical trials in Georgia

Pharmaceutical Technology

While nearby countries such as Romania and Poland see periods of four to six months for clinical trial application reviews, a timeline of two months can be granted in Georgia thanks to the harmonisation of the country’s legislation with international requirements. Expert partners.

article thumbnail

Unpacking the Financial Implications of EDC System Implementation: Initial Costs, Long-term Savings, and ROI

Cloudbyz

Electronic Data Capture (EDC) has revolutionized clinical research and pharmaceutical drug development. Direct costs include purchasing or licensing the EDC software, hardware acquisition (servers, devices), and system installation. However, adopting this system requires a significant financial commitment.

article thumbnail

New public Clinical Trials database leads to increased tax & regulatory transparency – risk of supply chain disruption / recall

Pharma Business Blog

Dears Please find hereinafter the latest news related to Clinical Trials in the EU with a respective indirect tax and pharma regulatory licensing impact: 1. The CTIS database is publicly available and leads to increased transparency for indirect tax & pharma regulatory licensing. • Indirect tax point of view b.)

article thumbnail

Can technology help diversify clinical trials?

pharmaphorum

The possibilities are endless, and in the context of trial participation and access to medicine technologies could assist: Reduced assessment times and hence increased patient compliance. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials. What comes next?

article thumbnail

Importer of Record for Clinical Trials

Imperical Blog

Avoiding “Customs Chaos” in Clinical Trials Means Working Closely with Your Importer of Record Many global clinical trial shipments get muddled regarding the critical role and responsibilities of the importer of record (IOR) for clinical trials.